Summary & Overview
HCPCS Level II J1738: Injection, meloxicam, 1 mg
Headline: HCPCS Level II code J1738 defines meloxicam injectable therapy for acute inflammatory pain
Lead: HCPCS Level II code J1738 denotes the single-dose injectable formulation of meloxicam (1 mg) used for therapeutic management of inflammatory pain. The code is relevant to outpatient and ambulatory infusion settings where parenteral NSAID therapy is administered.
What the code represents and why it matters: HCPCS Level II code J1738 identifies meloxicam provided as a 1 mg injection. Assigning the correct HCPCS Level II code ensures accurate billing for drug acquisition and administration in outpatient care, affecting reimbursement, inventory tracking, and clinical documentation.
Key payers covered: This analysis considers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
What readers will learn: The publication outlines billing benchmarks and payment considerations for HCPCS Level II code J1738, summarizes clinical context for meloxicam injection use, and flags relevant policy and coding items to watch. Specific payer coverage policies, modifier guidance, and related coding elements are addressed where available.
Scope: Content is written for a national audience and focuses on billing, clinical service type, and payer scope applicable across outpatient care settings.
Billing Code Overview
HCPCS Level II code J1738 describes Injection, meloxicam, 1 mg. This code represents a single-dose parenteral formulation of meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) used for acute treatment of inflammatory pain and related indications.
Service Type: Therapeutic injection / medication administration
Typical Site of Service: Outpatient clinic, physician office, or infusion center
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with chronic osteoarthritis of the knee, refractory to oral nonsteroidal anti-inflammatory drugs (NSAIDs) and topical therapies, presents to an outpatient infusion center for administration of parenteral meloxicam. The service is billed with J1738 (Injection, meloxicam, 1 mg). Typical workflow: the prescribing clinician documents the medical necessity and dosage; pre-procedure screening includes allergy review, platelet function/anticoagulation assessment, and informed consent for injectable therapy. On the day of service, nursing confirms identity, prepares the calculated dose under aseptic technique, and administers the slow intravenous or intramuscular injection per product labeling and facility protocol. Patient is observed briefly for immediate adverse reactions and discharged with written instructions and follow-up arranged with the prescribing clinician. Typical site of service is an outpatient infusion center, physician office with injection capability, or ambulatory surgical center when combined with other procedures. Eligible payors include commercial plans (Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, BUCA) and Medicare, each following their own coverage and billing rules for HCPCS J-codes.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard billing | Use when no special circumstances apply. |